ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,379,375, issued on Aug. 5, was assigned to Juno Therapeutics Inc. (Seattle).
"Methods for assessing cell surface glycosylation" was invented by Paul Ken Kodama (Seattle), Tom Kowski (Seattle), Mirna Mujacic (Seattle) and Kenneth Mayo Prentice (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for assessing cell surface glycans, e.g., N-glycans, by assessing a sample of released surface glycans, and determining the presence, absence, or level of glycans present in the sample. Also provided are methods of assaying and/or evaluating a cell composition by assessing the cell surface glycan profile of the cell composition and c...